Safety and Immunogenicity of an Investigational Pentavalent Meningococcal ABCYW Vaccine Against Meningococcal Disease in Children, Toddlers, and Infants
Clinical trial NCT06647407 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06647407
- Sponsor
- Sanofi Pasteur, a Sanofi Company
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-05
- Primary completion
- 2027-05-17
- Enrollment
- 750
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.